{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T02:12:39Z","timestamp":1792375959648,"version":"4.4.0"},"reference-count":139,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>As sarcoidosis may involve any organ, sarcoidosis patients should be evaluated for occult disease. Screening for some organ involvement may not be warranted if it is unlikely to cause symptoms, organ dysfunction, or affect clinical outcome. Even organ involvement that affects clinical outcome does not necessarily require screening if early detection fails to change the patient's quality of life or prognosis. On the other hand, early detection of some forms of sarcoidosis may improve outcomes and survival. This manuscript describes the approach to screening sarcoidosis patients for previously undetected disease. Screening for sarcoidosis should commence with a meticulous medical history and physical examination. Many sarcoidosis patients present with physical signs or symptoms of sarcoidosis that have not been recognized as manifestations of the disease. Detection of sarcoidosis in these instances depends on the clinician's familiarity with the varied clinical presentations of sarcoidosis. In addition, sarcoidosis patients may present with symptoms or signs that are not related to specific organ involvement that have been described as parasarcoidosis syndromes. It is conjectured that parasarcoidosis syndromes result from systemic release of inflammatory mediators from the sarcoidosis granuloma. Certain forms of sarcoidosis may cause permanent and serious problems that can be prevented if they are detected early in the course of their disease. These include (1) ocular involvement that may lead to permanent vision impairment; (2) vitamin D dysregulation that may lead to hypercalcemia, nephrolithiasis, and permanent kidney injury; and (3) cardiac sarcoidosis that may lead to a cardiomyopathy, ventricular arrhythmias, heart block, and sudden death. Screening for these forms of organ involvement requires detailed screening approaches.<\/jats:p>","DOI":"10.1055\/s-0040-1709496","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T22:35:42Z","timestamp":1597098942000},"page":"741-757","source":"Crossref","is-referenced-by-count":12,"title":["Screening Sarcoidosis Patients for Occult Disease"],"prefix":"10.1055","volume":"41","author":[{"given":"Marc A.","family":"Judson","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Albany Medical College, Albany, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2020,8,10]]},"reference":[{"issue":"06","key":"ref1","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1378\/chest.07-1178","article-title":"Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis","volume":"132","author":"A S Teirstein","year":"2007","journal-title":"Chest"},{"issue":"04","key":"ref2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","article-title":"Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes","volume":"104","author":"F Tavora","year":"2009","journal-title":"Am J Cardiol"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12016-014-8450-y","article-title":"The clinical features of sarcoidosis: a comprehensive review","volume":"49","author":"M A Judson","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"01","key":"ref4","first-page":"34","article-title":"What makes a screening exam \u201cgood\u201d?","volume":"8","author":"C Herman","year":"2006","journal-title":"Virtual Mentor"},{"issue":"02","key":"ref6","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders","volume":"16","author":"G W Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"05","key":"ref7","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1183\/09031936.00156314","article-title":"Negative clinical trials in sarcoidosis: failed therapies or flawed study design?","volume":"44","author":"D R Moller","year":"2014","journal-title":"Eur Respir J"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2214\/ajr.178.6.1781389","article-title":"Large coalescent parenchymal nodules in pulmonary sarcoidosis: \u201csarcoid galaxy\u201d sign","volume":"178","author":"M Nakatsu","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"ref9","first-page":"188","article-title":"Clinical aspects of ocular sarcoidosis","volume":"10","author":"K Ohara","year":"2005","journal-title":"Eur Respir J Monograph"},{"key":"ref10","first-page":"150","article-title":"Skin manifestations in sarcoidosis","volume":"10","author":"A Eklund","year":"2005","journal-title":"Eur Respir J Monograph"},{"issue":"03","key":"ref11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0002-9343(99)00223-5","article-title":"L\u00f6fgren's syndrome revisited: a study of 186 patients","volume":"107","author":"J Ma\u00f1\u00e1","year":"1999","journal-title":"Am J Med"},{"issue":"06","key":"ref12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2230.1994.tb01259.x","article-title":"Erythema nodosum-like eruption in sarcoidosis","volume":"19","author":"H Okamoto","year":"1994","journal-title":"Clin Exp Dermatol"},{"issue":"04","key":"ref13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1055\/s-0030-1262212","article-title":"Cutaneous sarcoidosis","volume":"31","author":"R M Marchell","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"issue":"07","key":"ref14","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archderm.141.7.869","article-title":"Development of sarcoidosis in cosmetic tattoos","volume":"141","author":"D D Antonovich","year":"2005","journal-title":"Arch Dermatol"},{"issue":"04","key":"ref15","first-page":"317","article-title":"Cutaneous sarcoidosis among Taiwanese","volume":"99","author":"S C Chao","year":"2000","journal-title":"J Formos Med Assoc"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MAJ.0b013e3181b97635","article-title":"Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbations","volume":"339","author":"B P McKinzie","year":"2010","journal-title":"Am J Med Sci"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1378\/chest.120.1.109","article-title":"Endobronchial biopsy for sarcoidosis: a prospective study","volume":"120","author":"A F Shorr","year":"2001","journal-title":"Chest"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/02770903.2012.747204","article-title":"Distinguishing asthma from sarcoidosis: an approach to a problem that is not always solvable","volume":"50","author":"A Kalkanis","year":"2013","journal-title":"J Asthma"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1378\/chest.100.1.96","article-title":"Crackles in interstitial lung disease. Comparison of sarcoidosis and fibrosing alveolitis","volume":"100","author":"R P Baughman","year":"1991","journal-title":"Chest"},{"issue":"03","key":"ref20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11916-011-0180-8","article-title":"Sarcoidosis and small-fiber neuropathy","volume":"15","author":"J Tavee","year":"2011","journal-title":"Curr Pain Headache Rep"},{"issue":"04","key":"ref21","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1034\/j.1399-3003.1999.13d03.x","article-title":"Association of fatigue with an acute phase response in sarcoidosis","volume":"13","author":"M Drent","year":"1999","journal-title":"Eur Respir J"},{"issue":"14","key":"ref22","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1212\/WNL.0b013e3181bacf05","article-title":"Intraepidermal nerve fiber density and its application in sarcoidosis","volume":"73","author":"M Bakkers","year":"2009","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(02)08912-2","article-title":"Small fibre neuropathy in sarcoidosis","volume":"359","author":"E Hoitsma","year":"2002","journal-title":"Lancet"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.rmed.2010.09.015","article-title":"Efficacy of intravenous immunoglobulin for small fiber neuropathy associated with sarcoidosis","volume":"105","author":"J G Parambil","year":"2011","journal-title":"Respir Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.rmed.2017.03.011","article-title":"Sarcoidosis-associated small fiber neuropathy in a large cohort: clinical aspects and response to IVIG and anti-TNF alpha treatment","volume":"126","author":"J O Tavee","year":"2017","journal-title":"Respir Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1093\/brain\/awn093","article-title":"The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology","volume":"131","author":"G Devigili","year":"2008","journal-title":"Brain"},{"issue":"03","key":"ref27","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1388-2457(02)00405-4","article-title":"Comparison of thermal threshold tests to assess small nerve fiber function: limits vs. levels","volume":"114","author":"J P Reulen","year":"2003","journal-title":"Clin Neurophysiol"},{"issue":"04","key":"ref28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.clinph.2004.10.004","article-title":"Laser-evoked potentials: normative values","volume":"116","author":"A Truini","year":"2005","journal-title":"Clin Neurophysiol"},{"issue":"05","key":"ref29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/ana.410140513","article-title":"Quantitative sudomotor axon reflex test in normal and neuropathic subjects","volume":"14","author":"P A Low","year":"1983","journal-title":"Ann Neurol"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1038\/s41598-018-23107-w","article-title":"Corneal nerve fiber size adds utility to the diagnosis and assessment of therapeutic response in patients with small fiber neuropathy","volume":"8","author":"M Brines","year":"2018","journal-title":"Sci Rep"},{"issue":"06","key":"ref31","doi-asserted-by":"crossref","first-page":"BIO52","DOI":"10.1167\/iovs.16-21291","article-title":"Cibinetide improves corneal nerve fiber abundance in patients with sarcoidosis-associated small nerve fiber loss and neuropathic pain","volume":"58","author":"D A Culver","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.2119\/molmed.2012.00332","article-title":"Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double-blind pilot study","volume":"18","author":"L Heij","year":"2012","journal-title":"Mol Med"},{"issue":"01","key":"ref33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1183\/09031936.00002512","article-title":"Sarcoidosis-associated fatigue","volume":"40","author":"M Drent","year":"2012","journal-title":"Eur Respir J"},{"issue":"03","key":"ref34","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ccm.2008.03.016","article-title":"Neurosarcoidosis","volume":"29","author":"E E Lower","year":"2008","journal-title":"Clin Chest Med"},{"issue":"02","key":"ref35","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1183\/13993003.01475-2015","article-title":"A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"47","author":"R Agarwal","year":"2016","journal-title":"Eur Respir J"},{"issue":"03","key":"ref36","first-page":"235","article-title":"The effects of fatigue and treatment with methylphenidate on sustained attention in sarcoidosis","volume":"22","author":"M T Wagner","year":"2005","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"02","key":"ref37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jpainsymman.2012.02.016","article-title":"Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial","volume":"45","author":"E E Lower","year":"2013","journal-title":"J Pain Symptom Manage"},{"issue":"05","key":"ref38","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1378\/chest.07-2952","article-title":"Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue","volume":"133","author":"E E Lower","year":"2008","journal-title":"Chest"},{"issue":"01","key":"ref39","first-page":"43","article-title":"Benefits of physical training in patients with idiopathic or end-stage sarcoidosis-related pulmonary fibrosis: a pilot study","volume":"32","author":"B Strookappe","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"05","key":"ref40","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00408-015-9784-9","article-title":"Benefits of physical training in sarcoidosis","volume":"193","author":"B Strookappe","year":"2015","journal-title":"Lung"},{"issue":"01","key":"ref41","first-page":"53","article-title":"Does physical training reduce fatigue in sarcoidosis?","volume":"32","author":"R Marcellis","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"06","key":"ref42","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1183\/09031936.00169413","article-title":"Association of the TNF-\u03b1 G-308A polymorphism with TNF-inhibitor response in sarcoidosis","volume":"43","author":"P A Wijnen","year":"2014","journal-title":"Eur Respir J"},{"issue":"05","key":"ref43","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00417-011-1844-0","article-title":"Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis","volume":"250","author":"R J Erckens","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"02","key":"ref44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1067\/mjd.2001.114736","article-title":"Panniculitis. Part I. Mostly septal panniculitis","volume":"45","author":"L Requena","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"04","key":"ref45","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.0954-6820.1952.tb13864.x","article-title":"The bilateral hilar lymphoma syndrome; a study of the relation to age and sex in 212 cases","volume":"142","author":"S Lofgren","year":"1952","journal-title":"Acta Med Scand"},{"issue":"04","key":"ref46","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1055\/s-0037-1602380","article-title":"L\u00f6fgren's syndrome: diagnosis, management, and disease pathogenesis","volume":"38","author":"B Karakaya","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"issue":"02","key":"ref47","first-page":"95","article-title":"Sarcoid arthritis: a review of clinical features, pathology and therapy","volume":"20","author":"K D Torralba","year":"2003","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"02","key":"ref48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3109\/03009749609069210","article-title":"Acute sarcoid arthritis: a favourable outcome? A retrospective survey of 49 patients with review of the literature","volume":"25","author":"J T Gran","year":"1996","journal-title":"Scand J Rheumatol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.rmed.2019.01.015","article-title":"The development of sarcoidosis in patients receiving daclizumab: a case series from multiple clinical trials","volume":"149","author":"M A Judson","year":"2019","journal-title":"Respir Med"},{"issue":"09","key":"ref50","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/00007611-199709000-00010","article-title":"Is there an anatomic explanation for chest pain in patients with pulmonary sarcoidosis?","volume":"90","author":"K B Highland","year":"1997","journal-title":"South Med J"},{"key":"ref51","first-page":"92","article-title":"Fatigue, quality of life and health status in sarcoidosis","volume":"32","author":"J De Vries","year":"2005","journal-title":"Eur Respir J Monograph"},{"issue":"11","key":"ref52","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.rmed.2008.05.001","article-title":"Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis","volume":"102","author":"B S Gvozdenovic","year":"2008","journal-title":"Respir Med"},{"issue":"04","key":"ref53","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1055\/s-0037-1602589","article-title":"Quality of life in sarcoidosis","volume":"38","author":"M A Judson","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"issue":"03","key":"ref54","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000314225","article-title":"Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF-alpha treatment","volume":"80","author":"M D Elfferich","year":"2010","journal-title":"Respiration"},{"issue":"03","key":"ref55","first-page":"275","article-title":"Causes of death in patients with chronic sarcoidosis","volume":"33","author":"X Hu","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"04","key":"ref56","first-page":"231","article-title":"Mortality in sarcoidosis. A changing pattern of the causes of death","volume":"62","author":"C T Huang","year":"1981","journal-title":"Eur J Respir Dis"},{"issue":"12","key":"ref57","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","article-title":"Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis","volume":"10","author":"V Kouranos","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"06","key":"ref58","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1378\/chest.07-2784","article-title":"Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing","volume":"133","author":"D Mehta","year":"2008","journal-title":"Chest"},{"issue":"07","key":"ref59","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"D H Birnie","year":"2014","journal-title":"Heart Rhythm"},{"issue":"01","key":"ref60","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1378\/chest.11-0263","article-title":"Management of cardiac sarcoidosis in the United States: a Delphi study","volume":"141","author":"N Y Hamzeh","year":"2012","journal-title":"Chest"},{"issue":"05","key":"ref61","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrcardio.2015.22","article-title":"Pathophysiology and clinical management of cardiac sarcoidosis","volume":"12","author":"N Hamzeh","year":"2015","journal-title":"Nat Rev Cardiol"},{"issue":"01","key":"ref62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2008.09.009","article-title":"Cardiac sarcoidosis","volume":"157","author":"J S Kim","year":"2009","journal-title":"Am Heart J"},{"issue":"03","key":"ref63","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ahj.2004.10.006","article-title":"A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy","volume":"150","author":"H Ardehali","year":"2005","journal-title":"Am Heart J"},{"issue":"10","key":"ref64","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jacc.2005.01.047","article-title":"Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis","volume":"45","author":"J P Smedema","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"02","key":"ref65","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/eurjhf\/hfs206","article-title":"Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure","volume":"15","author":"A Yoshida","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"02","key":"ref66","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"G Youssef","year":"2012","journal-title":"J Nucl Med"},{"issue":"01","key":"ref67","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.chest.2017.10.014","article-title":"Clinical course of sarcoidosis in World Trade Center-exposed firefighters","volume":"153","author":"K M Hena","year":"2018","journal-title":"Chest"},{"issue":"04","key":"ref68","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"R Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"04","key":"ref69","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis","volume":"10","author":"G C Coleman","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"32","key":"ref70","doi-asserted-by":"crossref","first-page":"e4518","DOI":"10.1097\/MD.0000000000004518","article-title":"Prevalence of cardiac sarcoidosis in white population: a case-control study: proposal for a novel risk index based on commonly available tests","volume":"95","author":"M M Martusewicz-Boros","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijcard.2016.10.101","article-title":"Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis","volume":"227","author":"S K Padala","year":"2017","journal-title":"Int J Cardiol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"R P Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"02","key":"ref73","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"M A Judson","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"01","key":"ref74","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/bjo.84.1.110","article-title":"Ocular involvement in sarcoidosis","volume":"84","author":"A Rothova","year":"2000","journal-title":"Br J Ophthalmol"},{"issue":"06","key":"ref75","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1055\/s-2002-36518","article-title":"Ocular manifestations of sarcoidosis","volume":"23","author":"D Bradley","year":"2002","journal-title":"Semin Respir Crit Care Med"},{"issue":"04","key":"ref76","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00004397-199030040-00008","article-title":"Ocular sarcoidosis","volume":"30","author":"M Mayers","year":"1990","journal-title":"Int Ophthalmol Clin"},{"key":"ref77","first-page":"388","article-title":"Lacrimal gland involvement in sarcoidosis. The clinical features of 9 patients","volume":"133","author":"H Yanardag","year":"2003","journal-title":"Swiss Med Wkly"},{"issue":"04","key":"ref78","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12348-011-0029-7","article-title":"Ocular disease awareness and pattern of ocular manifestation in patients with biopsy-proven lung sarcoidosis","volume":"1","author":"M Pefkianaki","year":"2011","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"04","key":"ref79","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ccm.2015.08.009","article-title":"Ocular sarcoidosis","volume":"36","author":"S Pasadhika","year":"2015","journal-title":"Clin Chest Med"},{"issue":"01","key":"ref80","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1172\/JCI109442","article-title":"Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis","volume":"64","author":"N H Bell","year":"1979","journal-title":"J Clin Invest"},{"issue":"05","key":"ref81","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1172\/JCI111147","article-title":"Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis","volume":"72","author":"J S Adams","year":"1983","journal-title":"J Clin Invest"},{"issue":"04","key":"ref82","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.161.4.755","article-title":"Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis","volume":"161","author":"J S Adams","year":"1985","journal-title":"J Exp Med"},{"issue":"14","key":"ref83","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1056\/NEJMcps1516629","article-title":"A bare-bones approach","volume":"376","author":"K Lavery","year":"2017","journal-title":"N Engl J Med"},{"issue":"09","key":"ref84","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1681\/ASN.V391555","article-title":"The kidney in sarcoidosis","volume":"3","author":"F J Casella","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"ref85","first-page":"220","article-title":"Renal sarcoidosis and hypercalcemia","volume":"32","author":"O P Sharma","year":"2005","journal-title":"Eur Respir J Monograph"},{"issue":"05","key":"ref86","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.ajkd.2006.07.022","article-title":"Sarcoidosis: the nephrologist's perspective","volume":"48","author":"A R Berliner","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"04","key":"ref87","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1055\/s-0030-1262215","article-title":"Calcium and vitamin D in sarcoidosis: how to assess and manage","volume":"31","author":"R R Burke","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"issue":"02","key":"ref88","first-page":"113","article-title":"Calcium and vitamin D metabolism in sarcoidosis","volume":"30","author":"R P Baughman","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"05","key":"ref89","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/MCP.0b013e328348b3cb","article-title":"How to diagnose and manage difficult problems of calcium metabolism in sarcoidosis: an evidence-based review","volume":"17","author":"V Vucinic","year":"2011","journal-title":"Curr Opin Pulm Med"},{"issue":"07","key":"ref90","doi-asserted-by":"crossref","first-page":"e230598","DOI":"10.1136\/bcr-2019-230598","article-title":"Rare case of parathyroid gland sarcoidosis presenting with hypercalcaemia","volume":"12","author":"B K Saha","year":"2019","journal-title":"BMJ Case Rep"},{"issue":"02","key":"ref91","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MD.0b013e31819de50f","article-title":"Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients","volume":"88","author":"M Mah\u00e9vas","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.rmed.2016.02.011","article-title":"The three tiers of screening for sarcoidosis organ involvement","volume":"113","author":"M A Judson","year":"2016","journal-title":"Respir Med"},{"issue":"02","key":"ref93","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.chest.2018.02.003","article-title":"Clinical features of extrapulmonary sarcoidosis without lung involvement","volume":"154","author":"W E James","year":"2018","journal-title":"Chest"},{"issue":"02","key":"ref94","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1600-0560.2009.01309.x","article-title":"Where does the antigen of cutaneous sarcoidosis come from?","volume":"37","author":"A Kurata","year":"2010","journal-title":"J Cutan Pathol"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"235142","DOI":"10.1155\/2011\/235142","article-title":"Adaptive immune responses in primary cutaneous sarcoidosis","volume":"2011","author":"M Bordignon","year":"2011","journal-title":"Clin Dev Immunol"},{"issue":"01","key":"ref96","first-page":"6","article-title":"How many organs need to be involved to diagnose sarcoidosis?: an unanswered question that, hopefully, will become irrelevant","volume":"31","author":"M A Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"04","key":"ref97","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0272-5231(05)70417-2","article-title":"Pulmonary sarcoidosis","volume":"18","author":"J P Lynch III","year":"1997","journal-title":"Clin Chest Med"},{"issue":"03","key":"ref98","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1183\/09031936.00025212","article-title":"Imaging of sarcoidosis of the airways and lung parenchyma and correlation with lung function","volume":"40","author":"H Nunes","year":"2012","journal-title":"Eur Respir J"},{"issue":"01","key":"ref99","first-page":"18","article-title":"Sensitivity and specificity of chest imaging for sarcoidosis screening in patients with cardiac presentations","volume":"36","author":"J J Russo","year":"2019","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/annrheumdis-2015-eular.4144","article-title":"SAT0551 sensitivity of chest radiography in the early diagnosis of sarcoidosis: is it really should be done?","volume":"74","author":"S Kobak","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"09","key":"ref101","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/S2213-2600(18)30216-9","article-title":"Are CT findings of pulmonary sarcoidosis ever sufficient for a presumptive diagnosis?","volume":"6","author":"D Naidich","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"03","key":"ref102","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.chest.2018.09.007","article-title":"Chest CT scan at radiation dose of a posteroanterior and lateral chest radiograph series: a proof of principle in lymphangioleiomyomatosis","volume":"155","author":"E Hu-Wang","year":"2019","journal-title":"Chest"},{"issue":"22","key":"ref103","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMra072149","article-title":"Computed tomography--an increasing source of radiation exposure","volume":"357","author":"D J Brenner","year":"2007","journal-title":"N Engl J Med"},{"issue":"02","key":"ref104","first-page":"131","article-title":"Hepatic granulomas: review of 73 patients from one hospital and survey of the literature","volume":"1","author":"S K Irani","year":"1979","journal-title":"J Clin Gastroenterol"},{"key":"ref105","first-page":"571","volume-title":"Hepatic and splenic sarcoidosis","author":"M A Judson","year":"2006"},{"issue":"01","key":"ref106","first-page":"73","article-title":"Course of asymptomatic liver involvement in sarcoidosis: role of therapy in selected cases","volume":"14","author":"R Vatti","year":"1997","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"04","key":"ref107","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF01318522","article-title":"Hepatic granulomatosis and sarcoidosis. Further observations","volume":"29","author":"H L Israel","year":"1984","journal-title":"Dig Dis Sci"},{"issue":"05","key":"ref108","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00005792-197009000-00002","article-title":"Sarcoidosis and chronic hepatic disease: a clinical and pathologic study of 20 patients","volume":"49","author":"W C Maddrey","year":"1970","journal-title":"Medicine (Baltimore)"},{"issue":"02","key":"ref109","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cld.2018.12.012","article-title":"Sarcoidosis and the liver","volume":"23","author":"M Kumar","year":"2019","journal-title":"Clin Liver Dis"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fmed.2019.00232","article-title":"Hepatic sarcoidosis: natural history and management implications","volume":"6","author":"M Sedki","year":"2019","journal-title":"Front Med (Lausanne)"},{"issue":"01","key":"ref111","first-page":"75","article-title":"Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A case control etiologic study of sarcoidosis","volume":"16","author":"M A Judson","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"01","key":"ref112","first-page":"19","article-title":"The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool","volume":"31","author":"M A Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"03","key":"ref113","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1148\/radiology.195.3.7754007","article-title":"Nodular sarcoidosis of the liver and spleen: analysis of 32 cases","volume":"195","author":"D M Warshauer","year":"1995","journal-title":"Radiology"},{"issue":"01","key":"ref114","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archinte.1980.00330130037013","article-title":"Splenomegaly in sarcoidosis","volume":"140","author":"Y P Kataria","year":"1980","journal-title":"Arch Intern Med"},{"issue":"10","key":"ref115","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/jcp.32.10.1050","article-title":"Splenomegaly and splenectomy in sarcoidosis","volume":"32","author":"A K Webb","year":"1979","journal-title":"J Clin Pathol"},{"issue":"04","key":"ref116","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1016\/j.amjmed.2016.11.033","article-title":"Massive splenomegaly indicating sarcoidosis","volume":"130","author":"C Bachmeyer","year":"2017","journal-title":"Am J Med"},{"issue":"03","key":"ref117","first-page":"229","article-title":"Thrombocytopenia in sarcoidosis","volume":"23","author":"M Mah\u00e9vas","year":"2006","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"04","key":"ref118","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/MD.0b013e31822618b3","article-title":"Association of sarcoidosis and immune thrombocytopenia: presentation and outcome in a series of 20 patients","volume":"90","author":"M Mah\u00e9vas","year":"2011","journal-title":"Medicine (Baltimore)"},{"issue":"02","key":"ref119","first-page":"146","article-title":"Pulmonary sarcoidosis and autoimmune hemolytic anemia: possible common immune pathogenesis","volume":"14","author":"R K Ghaddar","year":"2011","journal-title":"Arch Iran Med"},{"issue":"01","key":"ref120","first-page":"51","article-title":"The anemia of sarcoidosis","volume":"5","author":"E E Lower","year":"1988","journal-title":"Sarcoidosis"},{"issue":"04","key":"ref121","first-page":"419","article-title":"Bone marrow involvement in sarcoidosis: an analysis of 50 bone marrow samples","volume":"32","author":"H Yanarda\u011f","year":"2002","journal-title":"Haematologia (Budap)"},{"issue":"11","key":"ref122","first-page":"930","article-title":"Acquired functional asplenia in sarcoidosis","volume":"77","author":"R W Stone","year":"1985","journal-title":"J Natl Med Assoc"},{"issue":"01","key":"ref123","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1148\/radiology.192.1.8208972","article-title":"Abdominal CT findings in sarcoidosis: radiologic and clinical correlation","volume":"192","author":"D M Warshauer","year":"1994","journal-title":"Radiology"},{"issue":"04","key":"ref124","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00004728-199507000-00013","article-title":"Abdominal manifestations of sarcoidosis in CT studies","volume":"19","author":"S J Folz","year":"1995","journal-title":"J Comput Assist Tomogr"},{"issue":"01","key":"ref125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1148\/radiology.178.1.1984330","article-title":"Sarcoidosis: abdominal manifestations at CT","volume":"178","author":"A R Britt","year":"1991","journal-title":"Radiology"},{"issue":"03","key":"ref126","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00004728-199705000-00006","article-title":"CT patterns of nodular hepatic and splenic sarcoidosis: a review of the literature","volume":"21","author":"G C Scott","year":"1997","journal-title":"J Comput Assist Tomogr"},{"issue":"01","key":"ref127","doi-asserted-by":"crossref","first-page":"1700991","DOI":"10.1183\/13993003.00991-2017","article-title":"Phenotypes of organ involvement in sarcoidosis","volume":"51","author":"J C Schupp","year":"2018","journal-title":"Eur Respir J"},{"issue":"05","key":"ref128","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/MCP.0000000000000186","article-title":"How are cancer and connective tissue diseases related to sarcoidosis?","volume":"21","author":"A Chopra","year":"2015","journal-title":"Curr Opin Pulm Med"},{"issue":"06","key":"ref129","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1378\/chest.97.6.1284","article-title":"Renal sarcoidosis; a reminder","volume":"97","author":"M Akmal","year":"1990","journal-title":"Chest"},{"issue":"01","key":"ref130","first-page":"73","article-title":"Improvement of small fiber neuropathy in a sarcoidosis patient after treatment with infliximab","volume":"23","author":"E Hoitsma","year":"2006","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2119\/molmed.2013.00122","article-title":"ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density","volume":"19","author":"A Dahan","year":"2013","journal-title":"Mol Med"},{"issue":"05","key":"ref132","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/MCP.0b013e32832d0403","article-title":"Fatigue in sarcoidosis: a systematic review","volume":"15","author":"W P de Kleijn","year":"2009","journal-title":"Curr Opin Pulm Med"},{"issue":"01","key":"ref133","first-page":"57","article-title":"Relationship between perceived stress and sarcoidosis in a Dutch patient population","volume":"21","author":"J De Vries","year":"2004","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"02","key":"ref134","first-page":"127","article-title":"The relationship between fatigue and clinical parameters in pulmonary sarcoidosis","volume":"21","author":"J De Vries","year":"2004","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"04","key":"ref135","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1055\/s-0030-1262216","article-title":"Quality of life in sarcoidosis: assessment and management","volume":"31","author":"J De Vries","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"issue":"06","key":"ref136","first-page":"325","article-title":"The L\u00f6fgren syndrome: acute sarcoidosis (author's transl in German)]","volume":"30","author":"W Ponhold","year":"1977","journal-title":"Rontgenblatter"},{"issue":"03","key":"ref137","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1378\/chest.125.3.997","article-title":"Health-related quality of life of persons with sarcoidosis","volume":"125","author":"C E Cox","year":"2004","journal-title":"Chest"},{"issue":"02","key":"ref138","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1164\/ajrccm.163.2.2004177","article-title":"Depression in sarcoidosis","volume":"163","author":"B Chang","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"02","key":"ref139","first-page":"147","article-title":"Pulmonary and psychosocial findings at enrollment in the ACCESS study","volume":"22","author":"H Yeager","year":"2005","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref140","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.rmed.2017.11.008","article-title":"Everyday cognitive failure and depressive symptoms predict fatigue in sarcoidosis: a prospective follow-up study","volume":"138S","author":"C Hendriks","year":"2018","journal-title":"Respir Med"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0040-1709496.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T12:30:16Z","timestamp":1667737816000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0040-1709496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,10]]},"references-count":139,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2020,8,10]]},"published-print":{"date-parts":[[2020,10]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0040-1709496","relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,10]]}}}